Our team went through many data sources and prepared COVID-19 and the life sciences industry deck.
To download the deck, here is the link.
Topics covered in the deck:
- Basics about SARS-CoV-2 & COVID-19:
Overview
•Origin: Possibly in wet animal market in Wuhan, China
•Disease: Coronavirus disease 2019 (COVID-19)
•Cause: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
•Strain: Same virus as SARS-CoV-1, which affected 8,000 people in 2002-03
•DNA Study (Feb-2020): 96% DNA match between bat coronavirus and human suggests link to humans is not direct but through intermediate host
•Target: Upper respiratory tract and can spread to lungs
Transmission & Mechanism
•Enters through nose, mouth, or eyes
•Attaches to cells in the respiratory tract producing a protein called ACE2
•It fuses with the cell and releases the RNA
•The hijacked infected cell will produce proteins based on the “instructions” from the virus’ RNA
•Each infected cell can release millions of copies of the virus before dying
Characteristics
•Virus appears highly transmissible - Average patient infects 1.6 to 2.4 other people
•Affects older patients and fatality rate in the 70s is 3-4 times larger than the average
Men are twice more likely to get infected than women
COVID-19 Industry Impact Heatmap
- Key impacts of the COVID-19 pandemic on Life Sciences Companies:
The Slowdown of Economic Growth
Demand Disruption
Operations Disruption
Impact on Regulatory Function
Increase in Costs
Product Launch Delays
Virology Science
Clinical Trial Delays
- Short Term Action Plan for Life Sciences Companies
Secure Core Operations
Prioritize Clinical Trials
Revise Operating Model
Reduce Dependencies/Risks
- Long Term Action Plan for Life Sciences Companies
Re-evaluate Strategy Plans
Revise Operating Model
Boost Commercial Activities
Acquisitions & Divestments
Enterprise Risk Management
Resume R&D Activities
Ensure Business Continuity
- How can London Strategy help?
Re-evaluate Strategy Plans
Revise Operating Model
Boost Commercial Activities
Acquisitions & Divestments
Enterprise Risk Management
Operational Improvement
Ensure Business Continuity
- The response of the Life Sciences Industry
1. Diagnostics
Diagnostic Testing
The most pressing and immediate need in the battle against COVID-19
2. Treatments
Treatment Development
Pharma companies and biotechs are racing to develop an effective treatment for the COVID-19
3. Vaccine
Vaccine
Life Sciences companies are ratcheting up their efforts with accelerated schedules for creating new vaccines
Daily Deaths per Day by Country and Region. The death toll is on the rise once again
Mapping the Covid-19 outbreak. The pandemic spreads incredibly quickly between people. More than 10m people infected in appr. 6 months
Covid-19 situation in Europe & US
Comparison of Tests, Cases and Deaths
The Disease Progression
The Top 10 Countries in Reported Covid-19 deaths per Capita
Death rates 2020 vs Historical Averages by Country
Death rates 2020 vs Historical Averages by Urbans
Total COVID-19 tests per 1,000 vs. GDP per capita
Comparison of Tests vs Cases
Comparison of Median Age and Death Rate
The Countries with Critical Care Beds vs Active Cases
EU5 Summary: Hospital systems and COVID-19 testing
Covid-19 Major Events in Global
Timeline of US Government Responses to Covid-19
Timeline of EU5 Government Responses to Covid-19
Reopening Trends by Country
Reopening Trends of U.S
Reopening Trends by Geographies
Basics about SARS-CoV-2 & COVID-19
Anatomy of the Virus: SARS-CoV-2
Covid-19 Transmission & R0 Reproductive Number
Cellular Pathogenesis of the Virus: SARS-CoV-2
Covid-19 Disease Progression and Multi-Organ Injuries
Three Clinical Phases of Covid-19 Infection and Disease Progression
Almost 90% of Covid-19 Hospital Admissions involve Comorbidities
Potential Therapeutic Targets for SARS-CoV-2
History of Pandemic
